Telemedicine Not Breaking The Bank, Also Not Expanding Patient Access

Follow Drugslib on

By Dennis Thompson HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

TUESDAY, May 12, 2026 — Telemedicine appears to be breaking in the United States in both access and cost, a new study says.

It’s not costing the United States more in medical spending, but it also hasn’t led to dramatic expansion of access to health care, according to findings published May 11 in JAMA Network Open.

When the feds responded to the COVID-19 pandemic by relaxing telemedicine rules in 2020, some experts worried that the move would drive up healthcare costs, researchers said.

At the same time, proponents hoped the wider availability of telemedicine would help people without easy access to doctors.

“Our findings suggest neither prediction came true on a national scale,” said lead researcher Dr. John Mafi, an associate professor-in-residence at UCLA's David Geffen School of Medicine in Los Angeles.

“As telemedicine use grew, visits and spending in heavy users tracked closely with patterns in lighter users,” Mafi said in a news release. “That is reassuring for anyone worried about ballooning costs, but more sobering for anyone hoping telemedicine would close longstanding gaps in access. At least so far, it looks more like a substitute for in-person care than a true expansion of it.”

For the study, researchers analyzed medical claims for more than 3 million U.S. adults who had 120 million medical visits and incurred more than $178 billion in spending from 2019 to 2023.

Overall, researchers found that telemedicine visits fell by 2.4% during the study period and spending dropped 0.5%. However, these results were not statistically significant, meaning they might be explained by chance.

Urban dwellers had 4.4% fewer visits and 2.3% lower spending, while there were 3.4% more visits and 3.8% higher spending among rural residents – but again, these numbers were not statistically significant.

Researchers said it’s important to track these trends because the relaxed rules governing telemedicine are due to expire in 2027, and lawmakers continue to debate whether to extend or modify them.

These results should be considered an early read on a still-evolving medical landscape, said senior researcher Dr. Katherine Kahn, a professor of medicine at UCLA.

“Our analysis runs only through late 2023, when telemedicine use was still settling into a new equilibrium,” she said in a news release.

“Much more work is needed to understand telemedicine’s longer-term effects on quality of care, health outcomes and spending, and whether those effects differ across the diverse populations who depend on it,” Kahn said. “Policymakers should keep monitoring closely as the evidence base matures.”

Sources

  • UCLA, news release, May 11, 2026
  • JAMA Network Open, May 11, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-05-12 21:15

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords